Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Current Taxes: 2022-2024

Historic Current Taxes for Gyre Therapeutics (GYRE) over the last 3 years, with Dec 2024 value amounting to $2.8 million.

  • Gyre Therapeutics' Current Taxes fell 6.90% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year decrease of 6.90%. This contributed to the annual value of $2.8 million for FY2024, which is 43.98% down from last year.
  • Latest data reveals that Gyre Therapeutics reported Current Taxes of $2.8 million as of FY2024, which was down 43.98% from $5.1 million recorded in FY2023.
  • Gyre Therapeutics' 5-year Current Taxes high stood at $5.1 million for FY2023, and its period low was $2.1 million during FY2022.
  • Over the past 3 years, Gyre Therapeutics' median Current Taxes value was $2.8 million (recorded in 2024), while the average stood at $3.3 million.
  • As far as peak fluctuations go, Gyre Therapeutics' Current Taxes spiked by 140.55% in 2023, and later tumbled by 43.98% in 2024.
  • Yearly analysis of 3 years shows Gyre Therapeutics' Current Taxes stood at $2.1 million in 2022, then skyrocketed by 140.55% to $5.1 million in 2023, then tumbled by 43.98% to $2.8 million in 2024.